Melanoma Antigen Preferentially Expressed In Tumors (PRAME) Antibody (FITC)
169€ (20 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Melanoma Antigen Preferentially Expressed In Tumors (PRAME) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx344183
Description
Melanoma Antigen Preferentially Expressed In Tumors (PRAME) Antibody (FITC) is a Rabbit Polyclonal antibody conjugated to FITC for the detection of Human PRAME.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Melanoma Antigen Preferentially Expressed In Tumors (PRAME) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | FITC |
| Isotype | IgG |
| Purity | > 95% |
| Purification | Purified by Protein G chromatography. |
| Size 1 | 20 µg |
| Size 2 | 50 µg |
| Size 3 | 100 µg |
| Size 4 | 200 µg |
| Size 5 | 1 mg |
| Form | Liquid |
| Buffer | 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P78395 |
| Gene ID | 23532 |
| OMIM | 606021 |
| Background | Antibody anti-PRAME |
| Status | RUO |
Descripción
Related Products
Human PRAME (Melanoma antigen preferentially expressed in tumors) ELISA Kit
Ver Producto
PRAME antibody
Functions as a transcriptional repressor, inhibiting the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG. Prevents retinoic acid-induced cell proliferation arrest, differentiation and apoptosis.
Ver Producto